LBRX

38.8502.97%
JM

Joseph M. Miller

Chief Financial Officer

Mr. Joseph M. Miller, also known as Joe, is Chief Financial Officer of LB Pharmaceuticals Inc from September 3, 2026. He served as Chief Financial Officer of Aurinia Pharmaceuticals Inc. since April 27, 2020. He was responsible for developing and leading the Aurinia’s financial operations. He had been Director of Avalo Therapeutics, Inc. (formerly known as Cerecor Inc.) since April 24, 2020 until June 14, 2022. He had been Chief Financial Officer and Principal Financial Officer of Avalo Therapeutics, Inc. (formerly known as Cerecor Inc.) since July 16, 2018 until April 24, 2020, Principal Executive Officer from April 2019 to February 2020 and had been its Secretary. Mr. Miller was the Vice President of Finance at Sucampo Pharmaceuticals, Inc. from October 2015 to April 2018. In his previous role at Sucampo Pharmaceuticals, he was responsible for building out of the finance organization to effectively support the Sucampo’s rapid growth. Prior to Sucampo, he served in various progressive finance and management roles at Qiagen, Eppendorf and KPMG LLP. From 2006 to 2015, Mr. Miller was the Senior Director of Accounting at QIAGEN N.V. and from 2002 to 2006, he served as Vice President of Finance and Chief Financial Officer of Eppendorf-5 Prime. He served as a Treasurer and Vice President at Cerecor Inc and also serves as its Director since April 2020. Mr. Miller holds a B.S. degree in accounting from Villanova University and is a Certified Public Accountant.

公司职务